Related references
Note: Only part of the references are listed.SCID/NOD mice model for 5-FU induced intestinal mucositis: Safety and effects of probiotics as therapy
Lawrence Huang et al.
PEDIATRICS AND NEONATOLOGY (2019)
Administration of probiotic mixture DM#1 ameliorated 5-fluorouracil-induced intestinal mucositis and dysbiosis in rats
Yan Tang et al.
NUTRITION (2017)
Genomic characterization of the uncultured Bacteroidales family S24-7 inhabiting the guts of homeothermic animals
Kate L. Ormerod et al.
MICROBIOME (2016)
Chemotherapy-driven dysbiosis in the intestinal microbiome
E. Montassier et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Amelioration of Chemotherapy-Induced Intestinal Mucositis by Orally Administered Probiotics in a Mouse Model
Chun-Yan Yeung et al.
PLOS ONE (2015)
Pretreatment with Saccharomyces boulardii does not prevent the experimental mucositis in Swiss mice
Tatiani Uceli Maioli et al.
JOURNAL OF NEGATIVE RESULTS IN BIOMEDICINE (2014)
In Vitro Prevention of Salmonella Lipopolysaccharide-Induced Damages in Epithelial Barrier Function by Various Lactobacillus Strains
Chun-Yan Yeung et al.
GASTROENTEROLOGY RESEARCH AND PRACTICE (2013)
Inhibitory effects of Lactobacillus casei subsp rhamnosus on Salmonella lipopolysaccharide-induced inflammation and epithelial barrier dysfunction in a co-culture model using Caco-2/peripheral blood mononuclear cells
Hsu-Wei Fang et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2010)
Chemotherapy Treatment in Pediatric Patients with Acute Myeloid Leukemia Receiving Antimicrobial Prophylaxis Leads to a Relative Increase of Colonization with Potentially Pathogenic Bacteria in the Gut
Michel J. van Vliet et al.
CLINICAL INFECTIOUS DISEASES (2009)
Chemotherapy-Induced Modifications to Gastrointestinal Microflora: Evidence and Implications of Change
Andrea M. Stringer et al.
CURRENT DRUG METABOLISM (2009)
Gastrointestinal Microflora and Mucins May Play a Critical Role in the Development of 5-Fluorouracil-Induced Gastrointestinal Mucositis
Andrea M. Stringer et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2009)
Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile
Andrea M. Stringer et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2009)
Safety aspects and implications of regulation of probiotic bacteria in food and food supplements
Trudy M. Wassenaar et al.
JOURNAL OF FOOD PROTECTION (2008)
Lactobacillus fermentum BR11 and Fructo-Oligosaccharide Partially Reduce Jejunal Inflammation in a Model of Intestinal Mucositis in Rats
Cassie L. Smith et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2008)
Safety of probiotics: translocation and infection
Min-Tze Liong
NUTRITION REVIEWS (2008)
Lactobacillus supplementation for diarrhoea related to chemotherapy of colorectal cancer:: a randomised study
P. Osterlund et al.
BRITISH JOURNAL OF CANCER (2007)
Probiotic administration and the incidence of nosocomial infection in pediatric intensive care: A randomized placebo-controlled trial
Travis C. B. Honeycutt et al.
PEDIATRIC CRITICAL CARE MEDICINE (2007)
VSL#3 probiotic treatment reduces chemotherapy-induced diarrhea and weight loss
Joanne M. Bowen et al.
CANCER BIOLOGY & THERAPY (2007)
Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats
Mark S. Geier et al.
INTERNATIONAL JOURNAL OF FOOD MICROBIOLOGY (2007)
A five-strain probiotic combination reduces pathogen shedding and alleviates disease signs in pigs challenged with Salmonella enterica serovar typhimurium
Pat G. Casey et al.
APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)
Treatment of mucositis, including new medications
Rajesh V. Lalla et al.
CANCER JOURNAL (2006)
Analysis of 16S libraries of mouse gastrointestinal microflora reveals a large new group of mouse intestinal bacteria
NH Salzman et al.
MICROBIOLOGY-SGM (2002)
Share Paper
